Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 3 | $2.20 | $2.25 | $2.23 |
Q2 2025 | 2 | $2.23 | $2.33 | $2.27 |
Q3 2025 | 2 | $2.26 | $2.36 | $2.30 |
Q4 2025 | 2 | $2.03 | $2.12 | $2.07 |
Q1 2026 | 1 | $2.46 | $2.57 | $2.51 |
Q2 2026 | 1 | $2.43 | $2.54 | $2.48 |
Q3 2026 | 1 | $2.55 | $2.67 | $2.60 |
Q4 2026 | 1 | $2.13 | $2.23 | $2.17 |
Merck & Co., Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $1.57 earnings per share for the quarter, topping analysts' consensus estimates of $1.5 by $0.07. The company had revenue of 16.66 B for the quarter and had revenue of 60.12 B for the year. Merck & Co., Inc. has generated $0 earnings per share over the last year ($0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 20.77. Merck & Co., Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/06/2024 | Q3 2024 | $1.25 | $16.47 B | $16.66 B | ||
08/05/2024 | Q2 2024 | $2.15 | $15.87 B | $16.16 B | ||
05/03/2024 | Q1 2024 | $1.88 | $15.78 B | |||
04/11/2024 | Q4 2023 | -$0.48 | $14.63 B | |||
11/03/2023 | Q3 2023 | $1.87 | $15.30 B | $15.96 B | ||
08/07/2023 | Q2 2023 | -$2.35 | $14.44 B | $15.04 B | ||
05/05/2023 | Q1 2023 | $1.11 | $14.49 B | |||
02/24/2023 | Q4 2022 | $1.19 | $13.83 B | |||
11/03/2022 | Q3 2022 | $1.28 | $14.07 B | $14.96 B | ||
08/04/2022 | Q2 2022 | $1.56 | $13.86 B | $14.59 B | ||
05/05/2022 | Q1 2022 | $1.70 | $15.90 B | |||
02/25/2022 | Q4 2021 | $1.49 | $13.52 B | |||
11/05/2021 | Q3 2021 | $1.81 | $12.32 B | $13.15 B | ||
08/09/2021 | Q2 2021 | $0.61 | $11.23 B | $11.40 B | ||
05/05/2021 | Q1 2021 | $1.26 | $10.63 B | |||
02/25/2021 | Q4 2020 | -$0.83 | $12.52 B | |||
11/05/2020 | Q3 2020 | $1.16 | $12.21 B | $10.93 B | ||
08/05/2020 | Q2 2020 | $1.19 | $10.40 B | $9.35 B | ||
05/06/2020 | Q1 2020 | $1.28 | $12.06 B | |||
02/26/2020 | Q4 2019 | $0.93 | $11.87 B |
Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates.
In the previous quarter, Merck & Co., Inc. (:MRK) reported $1.57 earnings per share (EPS) to beat the analysts' consensus estimate of $1.5 by $0.07.
The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online.
The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online.
Merck & Co., Inc. (:MRK) has a recorded annual revenue of $60.12 B.
Merck & Co., Inc. (:MRK) has a recorded net income of $60.12 B. Merck & Co., Inc. has generated $0.14 earnings per share over the last four quarters.
Merck & Co., Inc. (:MRK) has a price-to-earnings ratio of 20.77 and price/earnings-to-growth ratio is -1.82.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED